Everand Logo

Welcome to Everand!

  • NPR

    Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests

    In a preliminary study, the cancer drug nilotinib seemed to help patients with Parkinson's and dementia. Now two larger and more rigorous studies of the drug are under way.
    by Jon Hamilton Mar 15, 2017 3 minutes
    A colored magnetic resonance imaging (MRI) scans of the brain of a 76-year-old patient with dementia shows the brain has atrophied and the dark brown fluid-filled spaces have become enlarged.

    Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's.

    The drug is nilotinib, which is approved to treat a form of leukemia.

    In late 2015, researchers at Georgetown University Medical Center that small doses of the drug appeared to help a handful of people with Parkinson's disease and a related form of dementia. They'd tried the unlikely treatment because they knew nilotinib triggered cells to get

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR3 min read
    5 Workers Dead, Dozens Still Missing After A Building Collapsed In South Africa
    Rescue teams worked searching for dozens of construction workers buried under the rubble after a multi-story apartment complex that was being built collapsed in a coastal city in South Africa.
    NPR2 min readInternational Relations
    Israeli Forces Take Control Of The Gaza Side Of The Rafah Crossing With Egypt
    An Israeli tank brigade seized control Tuesday of the Gaza Strip side of the Rafah border crossing with Egypt, authorities said, as cease-fire negotiations with Hamas remain on a knife's edge.
    NPR2 min readDiscrimination & Race Relations
    Biden Decries Surge Of Antisemitism Since The October 7 Hamas Attacks On Israel
    President Biden spoke out against harassment of Jewish students on college campuses, part of what he called a "ferocious surge of antisemitism" seen since Oct. 7.

    Related Books & Audiobooks